RxDoctor Payments Data

Thomas Conroy

Corneal and Contact Management · Bloomfield, NJNPI 1679539662

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Among corneal and contact management clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,562in general payments, 2019–2025

Across 387 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Bausch & Lomb Americas Inc.$1K
  • Alcon$904
  • Dompe US, Inc.$778
  • Tarsus Pharmaceuticals, Inc.$762
  • Biotissue Holdings Inc.$761
  • plus $2K from 17 others

What the payments were for

  • Food & beverage$8,562100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,562 in reported general payments places this provider in the 90th percentile of 45 corneal and contact management providers in New Jersey.

See all corneal and contact management providers in New Jersey

Medicare billing

Part B allowed, 2024
$32,221
Medicare patients
187
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone30$1,087
Ketorolac Tromethamine20$935
Prednisolone Acetate20$634
Latanoprost51$349
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha20$213

Paid to pharmacies, not to this prescriber.

Other corneal and contact management in Bloomfield

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →